
Musicians in the electronic dance music scene are increasingly concerned about the rise of AI-generated tracks, which they believe threaten the authenticity of the genre. Artists like Max 'H4RRIS' Harris are actively identifying and calling out tracks they suspect are created using AI, arguing that these lack the emotional and creative depth of human-made music. This has led to a culture of mistrust, as musicians fear their work is being mimicked and profited from by AI tools. The situation highlights the ongoing tension between technological innovation and the preservation of artistic integrity.
Read original
© The Verge AISony Music Publishing and Warner Chappell have taken legal action against Anthropic, accusing the AI firm of extensive copyright violations. Filed in California, the lawsuit seeks substantial damages for the alleged unauthorized use of copyrighted works in training Anthropic's AI models, potentially reaching billions of dollars. This legal move underscores the ongoing conflict between AI developers and content creators over intellectual property rights. A successful outcome for the plaintiffs could establish new standards for how AI companies incorporate copyrighted material into their training datasets.
© The Verge AIA federal judge has determined that the Pentagon's blacklisting of AI company Anthropic was unconstitutional, marking a pivotal legal win for the firm. The court found that the Trump administration's actions were an unlawful response to Anthropic's refusal to permit its AI technology for mass surveillance or lethal autonomous weapons. This decision highlights the ongoing conflict between AI companies and government agencies over the ethical use of technology. With this ruling, Anthropic can proceed with its operations without the limitations of being labeled a supply chain risk, potentially reshaping its interactions with the Department of Defense.
© The Verge AIGoogle's Gemini Notebook has introduced a new 'Expert Intelligence' feature that allows users to interact with books purchased from Google Play Books. This integration enables users to ask questions, generate content like infographics and podcasts, and even view full texts within the app. With support from over 100,000 books and collaborations with authors like Michael Pollan and Kim Scott, this feature aims to enhance the note-taking experience by providing personalized insights and content creation tools. This move not only enriches user engagement but also opens new revenue streams for authors and publishers.
© TechCrunch AICaterpillar is leveraging its extensive experience in automating mining operations to deploy AI across more dynamic environments like construction sites and quarries. The company has developed tools such as the Cat AI Assistant, which aids technicians with voice-activated repair procedures, drawing on data from 1.6 million connected assets. This move is part of a broader strategy to integrate AI into its operations, including site scanning and digital twin creation. As Caterpillar transitions to more autonomous systems, it faces the challenge of training its workforce, with a $100 million investment planned over five years to upskill employees in AI and robotics.
© TechCrunch AISony Music Publishing and Warner Chappell have filed a lawsuit against AI lab Anthropic, accusing it of illegally using copyrighted music to train its AI model, Claude. The lawsuit claims Anthropic engaged in unauthorized torrenting and downloading of copyrighted works, a charge Anthropic denies and plans to contest in court. This legal action follows a similar case where Anthropic was ordered to pay $1.5 billion for acquiring content through piracy. The outcome of this lawsuit could have significant implications for how AI companies source training data, especially in the creative industries.
© TechCrunch AIVijay Pande, who previously managed $4 billion at a16z, has embarked on a new venture, VZVC, which adopts a more focused investment strategy in biotech by making a few concentrated bets each year. This transition to a smaller, AI-driven firm marks a strategic shift towards utilizing AI in drug discovery and clinical trials. Pande discusses the unique challenges in AI-driven biotech, particularly the necessity for proprietary datasets, as biological data isn't readily available online like text. This approach seeks to tackle inefficiencies in drug development and precision medicine, potentially transforming how treatments are personalized for individuals.